The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice
- 1 March 1992
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 118 (3) , 187-189
- https://doi.org/10.1007/bf01410132
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer modelsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Progesterone antagonists block the growth of experimental mammary tumors in G0/G1Breast Cancer Research and Treatment, 1990
- The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell deathJournal of Steroid Biochemistry, 1989
- Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studiesBreast Cancer Research and Treatment, 1989
- Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the ratEuropean Journal of Cancer and Clinical Oncology, 1989
- Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cellsBreast Cancer Research and Treatment, 1987
- Characterization of the T61 human breast carcinoma established in nude miceEuropean Journal of Cancer and Clinical Oncology, 1985
- Endocrine sensitivity of the receptor-positive T61 human breast carcinoma serially grown in nude miceInternational Journal of Cancer, 1985
- New steroids with antiprogestational and antiglucocorticoid activitiesSteroids, 1984
- Criteria for the Establishment of a Double-Labeling Assay for Simultaneous Determination of Estrogen and Progesterone ReceptorsOncology, 1984